Identification of tyrosine 806 as a molecular determinant of RET kinase sensitivity to ZD6474
Francesca Carlomagno(CEINGE Biotecnologie Avanzate Franco Salvatore (Italy)), Massimo Santoro(Institute for Experimental Endocrinology and Oncology)
Cited by 40
Related Papers
BAY 43-9006 Inhibition of Oncogenic RET Mutants
|JNCI Journal of the National Cancer Institute|2006|471
The Extent of Linkage Disequilibrium in Four Populations with Distinct Demographic Histories
|The American Journal of Human Genetics|2000|182
Sorafenib Inhibits Imatinib-Resistant KIT and Platelet-Derived Growth Factor Receptor β Gatekeeper Mutants
|Clinical Cancer Research|2007|73
The tyrosine kinase inhibitor ZD6474 blocks proliferation of RET mutant medullary thyroid carcinoma cells
|Endocrine Related Cancer|2010|73
Targeted activity of the small molecule kinase inhibitor Pz-1 towards RET and TRK kinases
|Scientific Reports|2021|17